ADD CONDITION

items per page

Electrum Numb Anesthetic

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Lidocaine Hydrochloride 4.48 g/112 g
Other brand names
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2020
Label revision date
March 20, 2024
Active ingredient
Lidocaine Hydrochloride 4.48 g/112 g
Other brand names
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2020
Label revision date
March 20, 2024
Manufacturer
RENU LABORATORIES, INC.
Registration number
M017
NDC root
76348-600

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Electrum Spray is a medication designed to provide temporary relief from pain associated with minor skin procedures. It is used to help ease discomfort during these procedures, making the experience more manageable for you. If you're undergoing a minor skin treatment, Electrum Spray may be a helpful option to consider for pain relief.

Uses

You can use this medication for the temporary relief of pain associated with minor skin procedures. It is designed to help make these procedures more comfortable by reducing discomfort during the process.

Rest assured, there are no teratogenic effects (which means it does not cause birth defects) or nonteratogenic effects noted with this medication. This makes it a safe option for those needing pain relief in the context of minor skin treatments.

Dosage and Administration

When using this medication, if you are an adult or a child over 12 years old, you should apply a thin layer to the affected area every 6 to 8 hours. However, make sure not to apply it more than three times in a 24-hour period. After you apply the medication, it’s important to wash your hands with soap and water to avoid spreading it to other areas.

If you are considering this medication for a child who is 12 years old or younger, it’s best to consult a doctor first to ensure it’s safe and appropriate for their use.

What to Avoid

It's important to use this medication safely to avoid potential issues. You should not apply it to large areas of your body or on skin that is cut, irritated, or swollen. Additionally, avoid using it on puncture wounds. If you find that you need to use this medication for more than one week, please consult your doctor for guidance. Following these instructions will help ensure your safety and the effectiveness of the treatment.

Side Effects

This product is intended for external use only. You should stop using it and consult a doctor if your condition worsens, if you notice redness or irritation, or if your symptoms last more than seven days. Additionally, if your symptoms improve and then return within a few days, or if you experience signs of skin injury—such as pain, swelling, or blistering at the application site—seek medical advice promptly.

Warnings and Precautions

This product is for external use only, so please avoid ingesting it. Keep it out of reach of children and pets. If someone accidentally swallows it, seek medical help or contact a poison control center immediately.

You should stop using the product and call your doctor if your condition worsens, if you notice any redness or irritation, if symptoms last longer than 7 days, or if they clear up and then return within a few days. Additionally, if you experience any signs of skin injury, such as pain, swelling, or blistering at the application site, it's important to consult your doctor.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are concerned about a possible overdose, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get professional assistance if you think you or someone else may have taken too much of a medication. Remember, timely intervention can be crucial in these situations.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

If you have a child who is 12 years old or younger, it's important to consult with a doctor before using this medication. For children over 12 years and adults, you can apply a thin layer of the medication to the affected area every 6 to 8 hours. However, be sure not to exceed three applications within a 24-hour period to ensure safety and effectiveness. Always follow these guidelines to help keep your child safe while using this treatment.

Geriatric Use

While there is no specific information available about the use of this medication in older adults, it’s important to approach any new treatment with caution. Since older adults may have different health needs and responses to medications, you should always consult with a healthcare provider before starting any new medication. They can help determine the right dosage and monitor for any potential side effects, ensuring that the treatment is safe and effective for you or your loved one.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment is safe and effective, especially if you have concerns about your kidney health. They can provide guidance based on your individual situation.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (liver issues).

Before starting any new medication, including this one, you should discuss your liver health with your healthcare provider. They can help determine the best approach for your treatment and ensure your safety.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking. In this case, there are no specific drug interactions or laboratory test interactions noted, which means that the medication may not have known conflicts with other drugs or tests. However, every individual is different, and your healthcare provider can help ensure that your treatment is safe and effective based on your unique health situation.

Always remember that discussing your full list of medications and any lab tests with your healthcare provider is crucial. This way, you can avoid any potential issues and receive the best care possible.

Storage and Handling

To ensure the best performance of your product, store it at a temperature between 20-25°C (68-77°F). This temperature range helps maintain the integrity and effectiveness of the device.

When handling the product, make sure to do so in a clean environment to avoid contamination. Always follow any specific instructions provided for safe use and disposal to ensure your safety and the safety of others.

Additional Information

You should apply a thin layer of the medication to the affected area every 6 to 8 hours, but do not exceed three applications in a 24-hour period. If you are pregnant or breastfeeding, it's important to consult a healthcare professional before using this product. Keep it out of reach of children and pets, and if swallowed, seek medical help or contact a poison control center immediately.

FAQ

What is ELECTRUM SPRAY used for?

ELECTRUM SPRAY is used for the temporary relief of pain associated with minor skin procedures.

How should I apply ELECTRUM SPRAY?

For adults and children over 12 years, apply a thin layer to the affected area every 6 to 8 hours, not exceeding 3 applications in a 24-hour period.

What should I do after applying ELECTRUM SPRAY?

After applying, wash your hands with soap and water.

Can I use ELECTRUM SPRAY on children under 12?

You should ask a doctor before using ELECTRUM SPRAY on children 12 years or younger.

Are there any warnings for using ELECTRUM SPRAY?

Yes, it is for external use only, and you should avoid contact with eyes and mucous membranes.

What should I do if my condition worsens while using ELECTRUM SPRAY?

Stop use and ask a doctor if your condition worsens, if redness or irritation develops, or if symptoms persist for more than 7 days.

Is there any specific storage requirement for ELECTRUM SPRAY?

Store ELECTRUM SPRAY at 20-25° C (68 - 77°F).

What should I do if I accidentally swallow ELECTRUM SPRAY?

If swallowed, get medical help or contact a poison control center right away.

Can I use ELECTRUM SPRAY if I am pregnant or breastfeeding?

If you are pregnant or breastfeeding, you should ask a health professional before using ELECTRUM SPRAY.

Are there any contraindications for using ELECTRUM SPRAY?

No specific contraindications are mentioned, but do not use it on large areas of the body or on cut, irritated, or swollen skin.

Packaging Info

Below are the non-prescription pack sizes of Electrum Numb Anesthetic (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Electrum Numb Anesthetic.
Details

Drug Information (PDF)

This file contains official product information for Electrum Numb Anesthetic, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

Electrum Spray is presented in a media type of image/jpeg. The reference for this product is identified as NUMB SPRAY 4 oz.jpg.

Uses and Indications

This drug is indicated for the temporary relief of pain associated with minor skin procedures.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children over 12 years of age, a thin layer of the medication should be applied to the affected area every 6 to 8 hours. The total number of applications must not exceed three times within a 24-hour period. Following application, it is essential to wash hands thoroughly with soap and water to prevent unintentional contact with other areas of the body or with other individuals.

For children aged 12 years or younger, it is advised to consult a physician before use to determine appropriate dosing and administration.

Contraindications

Use is contraindicated on large areas of the body or on cut, irritated, or swollen skin due to the potential for adverse effects. Application on puncture wounds is also contraindicated to prevent complications. Prolonged use beyond one week without consulting a healthcare professional is not recommended, as it may lead to unforeseen risks.

Warnings and Precautions

For external use only. It is imperative that this product is kept out of reach of children and pets to prevent accidental ingestion or misuse. In the event of ingestion, immediate medical assistance should be sought, or a poison control center should be contacted without delay.

Healthcare professionals should advise patients to discontinue use and consult a physician if any of the following occur: worsening of the condition, presence of redness, development of irritation, persistence of symptoms beyond 7 days, or recurrence of symptoms after initial improvement. Additionally, patients should be instructed to seek medical attention if they experience signs of skin injury, including pain, swelling, or blistering at the site of application.

In cases of accidental ingestion, it is crucial to obtain emergency medical help or contact a poison control center immediately.

Side Effects

For external use only. Patients should discontinue use and consult a healthcare professional if any of the following occur: the condition worsens, redness is present, irritation develops, symptoms persist for more than 7 days, or symptoms clear up and then recur within a few days. Additionally, individuals should seek medical advice if they experience signs of skin injury, such as pain, swelling, or blistering at the site of application.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Electrum Numb Anesthetic (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Electrum Numb Anesthetic.
Details

Pediatric Use

Pediatric patients 12 years of age or younger should consult a healthcare professional before use. For adolescents and children over 12 years, the recommended dosage is to apply a thin layer to the affected area every 6 to 8 hours, with a maximum of 3 applications within a 24-hour period.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure the safety of both the mother and the developing fetus.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, and respiratory distress.

In the event of an overdose, immediate medical intervention is recommended. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is crucial to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable. Continuous assessment and supportive measures should be prioritized until the patient stabilizes or further treatment is determined.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is vital for ongoing management and potential reporting to regulatory authorities.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use.

Rare instances of serious burns have been documented with products of this nature. Additionally, a transient burning sensation may occur upon application; however, this sensation typically resolves within several days.

No specific information is available regarding nonclinical toxicology or animal pharmacology and toxicology in the insert.

Postmarketing Experience

Rare cases of serious burns have been reported in association with products of this type. These events were identified through voluntary reporting and surveillance programs.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children and pets to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a poison control center immediately.

Patients should be informed not to use the product on large areas of the body or on cut, irritated, or swollen skin, and to avoid application on puncture wounds. It is important to counsel patients that they should not use the product for more than one week without consulting a doctor.

Patients should be instructed to stop using the product and consult a doctor if their condition worsens, if redness is present, if irritation develops, or if symptoms persist for more than seven days or clear up and then recur within a few days. Additionally, they should seek medical advice if they experience signs of skin injury, such as pain, swelling, or blistering at the application site.

When using the product, patients should be reminded to follow all directions and warnings on the label carefully. They should be made aware that rare cases of serious burns have been reported with similar products. It is crucial to inform patients not to bandage or apply local heat, such as heating pads, to the area of use, nor to use it in conjunction with a medicated patch.

Patients should also be cautioned to avoid contact with eyes and mucous membranes. A transient burning sensation may occur upon application, but this generally resolves within several days.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It should be stored at a controlled room temperature of 20-25°C (68-77°F) to ensure optimal stability and efficacy. Proper container requirements must be adhered to, and special handling considerations should be observed to maintain the integrity of the product throughout its shelf life.

Additional Clinical Information

The product is administered topically, with a recommended application of a thin layer to the affected area every 6 to 8 hours for adults and children over 12 years, not exceeding three applications within a 24-hour period.

Clinicians should counsel patients to consult a health professional if they are pregnant or breastfeeding before use. It is important to keep the product out of reach of children and pets. In the event of accidental ingestion, patients should seek medical assistance or contact a poison control center immediately.

Drug Information (PDF)

This file contains official product information for Electrum Numb Anesthetic, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Electrum Numb Anesthetic, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.